Pending additional studies confirming their value in NFPA, measuring expression of MGMT, somatostatin and dopamine receptors, PD-1/PD-L1, CTLA-4, and VEGF can be done routinely on resected tissue in patients with aggressive tumors. The gene discussed is CD274; the disease is non-functioning pituitary adenoma.